目的 评价SRM-Ⅳ眩晕诊疗系统辅助治疗前庭神经元炎引起眩晕的疗效。方法 选取2017-01至2018-12医院收治的诊断为前庭神经元炎患者144例进行随机分组,对照组72例行对症药物治疗,治疗组72例在对症治疗基础上接受SRM-Ⅳ眩晕诊疗系统辅助治疗,并在治疗后对两组眩晕等症状的改善及取得疗效时间进行评价和比较。结果 治疗组总有效率为95.8%,对照组总有效率为79.2%,两者差异有统计学意义(χ2=9.143,P=0.002);治疗组取得疗效中位时间眩晕2 d短于对照组4 d(Z=2.060,P=0.000),呕吐1 d短于对照组2 d(Z=1.873,P=0.002)。结论 常规对症治疗基础上行SRM-Ⅳ眩晕诊疗系统辅助治疗能减轻前庭神经元炎引起的眩晕,并能缩短眩晕和呕吐持续时间。
Abstract
Objective To evaluate the efficacy of the SRM-IV vertigo diagnosis and treatment system in adjuvant treatment of vertigo caused by vestibular neuritis.Methods One hundred and forty-four patients with vestibular neuritis diagnosed in our hospital between 2017 and 2018 were randomly and equally divided into two groups: the control group that was treated with routine drugs and the treatment group that was additionally treated with the SRM-Ⅳ vertigo diagnosis and treatment system. The efficacy and the time taken to achieve curative effect were evaluated and compared between the two groups.Results The total effective rate was 95.8% in the treatment group and 79.2% in the control group, with significant difference (χ2= 9.143,P=0.002). The average time taken to achieve curative effect in the treatment group was 2 days into vertigo, shorter than 4 days in the control group(Z=2.060,P=0.000).Vomiting lasted one day in the treatment group,shorter than 2 days in the control group(Z=1.873,P=0.002).Conclusions The SRM-Ⅳ vertigo diagnosis and treatment system based on conventional symptomatic treatment can effectively alleviate vertigo caused by vestibular neuritis and shorten the duration of vertigo and vomiting.
关键词
SRM-Ⅳ眩晕诊疗系统 /
前庭神经元炎 /
眩晕
Key words
SRM-Ⅳ vertigo diagnosis and treatment system /
vestibular neuritis /
vertigo
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 王朝霞,徐先荣.前庭神经元炎的诊治与航空医学鉴定[J].临床耳鼻咽喉头颈外科杂志, 2017,31(8):82-86.
[2] Baloh R W. Clinical practice. Vestibular neuritis.[J].N Engl J Med,2003, 348(11):1027-1032.
[3] 刘 钢,翟 翔.前庭神经元炎引起眩晕的诊断、鉴别诊断及治疗原则[J].中国现代神经疾病杂志,2005,5(5): 308-309.
[4] 闫亚平,刘有凤,张淑香,等.听神经瘤误诊误治1例[J].武警医学, 2014, 25(5):512-513.
[5] 王 泳.眩晕的发病机制与分类[J].中国社区医师, 2004, 20(8):7-8.
[6] 刘 媛.应用纳络酮治疗前庭神经元炎引起眩晕的效果分析[J].海峡药学,2013,25(7):161.
[7] 赵洪鉴.银丹心脑通软胶囊治疗前庭神经元炎的临床观察[J].中国社区医师(医学专业), 2012, 14(33):166.
[8] 原红艳,张淑香. SRM -Ⅳ前庭功能诊疗系统治疗良性阵发性位置性眩晕疗效分析[J]. 听力学及言语疾病杂志, 2014(3):308-310.
[9] Mandalà M, Santoro G P, Awrey J, et al. Vestibular neuritis: recurrence and incidence of secondary benign paroxysmal positional vertigo[J]. Acta Otolaryngol,2010, 130(5):565-567.
[10] Balatsouras D G, Koukoutsis G, Ganelis P, et al. Benign paroxysmal positional vertigo secondary to vestibular neuritis[J]. Eur Arch Otorhinolaryngol, 2014, 271(5):919-924.
[11] Deveze A, Bernarddemanze L, Xavier F, et al. Vestibular compensation and vestibular rehabilitation. Current concepts and new trends.[J]. Neurophysiol Clin,2014, 44(1):49-57.
[12] 陈 瑛, 赵忠新, 庄建华,等. 前庭康复在急性前庭神经炎治疗中的效果评价[J]. 医学研究杂志, 2015, 44(5):61-63.
[13] 张素珍. 眩晕症的诊断与治疗[M].北京:人民军医出版社, 2014: 264-265.
[14] 普朗斯坦, 伦珀特, 赵 钢,等.眩晕和头晕: 实用入门手册[M]. 北京:华夏出版社, 2012:64-68.
PDF(585 KB)
